Oncotarget is a peer-reviewed open access biomedical journal that covers research on all aspects of oncology and other biomedical topics. It was established in the year 2010 and has made great strides since then, under the leadership of able prominent scientists. The journal, published by Impact Journal, has been commended by Medline in its statement of 22nd June 2017 as a journal that continues to play a significant role in the publication of scientific research papers marked by insightful reviews.

Since its inception, Oncotarget has published several volumes and is now at its eighth volume. Not long after its online publication, Ocotarget has gone ahead to give an entire issue to PubMed for publication. Its scientific papers are also available on other scientific publications including PubMed Central and ISI/Web of Science. The journal has gone ahead to work closely with high profile scientific indexes and archives. Watch this video on Youtube.

In its mission to meet the challenges of the 21st century, Oncotarget has initiated twice-weekly publication. The publications are available on Tuesday and Friday weekly, making dissemination more efficient. It got captured in an article published on PR Newswire on September 19, 2017.

Out of its close relations with high profile scientific indices and archives, Oncotarget can avail research results rapidly to those who need it. The indexing process will get enhanced by the bi-weekly publication initiated by Oncotarget. The issues are meant to appear on PubMed permanently once they get assigned page and issue numbers. Learn more about Oncotarget at Eurekalert.org.

Oncotarget is known for insightful reviews. For instance, an article published on research gate, titled ‘Oncotarget, Advance Publications 2017 provided a systematic and reliable review of literature reviews. It covered an identified 185 relevant reviews, spanning over the last ten years.

The article explores the role played by oxidative stress in cancer initiation. Mainly, the review delves into the effects of oxidative stress on species that do react to oxygen or those species that are reactive to nitrogen. The molecular damage coupled with a disruption of the redox signaling contributes to the formation of cancer. The article gives an insightful review touching on the reduction-oxidation pathways in reviews of 2005 to 2015.

Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/